HGA
OFIX icon

Hobbs Group Advisors’s Orthofix Medical OFIX Stock Holding History

Hobbs Group Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25
Closed -$391 – 461
2024
Q3 		$391 Hold
25
– – ﹤0.01% 638
2024
Q2 		$332 Buy
+25
New +$343 ﹤0.01% 596
2023
Q4 		$337 Buy
+25
New +$294 ﹤0.01% 530

Other funds holding OFIX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hobbs Group Advisors's OFIX Position: Q4 2024 in Review

Hobbs Group Advisors sold out of Orthofix Medical (OFIX) in Q4 2024, closing a stake of 25 shares — an estimated $391 sold.

Hobbs Group Advisors first reported a position in OFIX in Q4 2023 and held it in 3 quarters. The position peaked at $391 in Q3 2024. 149 funds tracked by Wall St. Rank hold OFIX as of Q4 2024.

  • Hobbs Group Advisors reported no remaining Orthofix Medical position as of Q4 2024 after selling out during the quarter.
  • Hobbs Group Advisors sold 25 Orthofix Medical shares in Q4 2024, an estimated $391.
  • Hobbs Group Advisors first reported a position in Orthofix Medical in Q4 2023 and held it in 3 quarters.
  • Hobbs Group Advisors's Orthofix Medical position peaked at $391 in Q3 2024.
  • 149 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2024.

Based on Hobbs Group Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.